The KDIGO guidelines recommend treatment strategies aimed at preventing vascular and skeletal complications across the stages of CKD and provide target ranges for phosphate, calcium, and PTH in dialysis patients [55]. The gene discussed is PTH; the disease is chronic kidney disease.